Fetal and Neonatal Monitoring Devices Market

USD 4.3 billion in 2026 to USD 8.7 billion by 2036 at a 7.2% CAGR.

• As per Fact.MR analysis, the fetal and neonatal monitoring devices market reached USD 4.01 billion in 2025.
• Demand will increase from USD 4.3 billion in 2026 to USD 8.7 billion by 2036.
• The fetal and neonatal monitoring devices market will record 7.2% CAGR from 2026 to 2036.
   

Source: Fact.MR analysis. Updated Oct 12, 2026

What are the defining numbers behind Fetal and Neonatal Monitoring Devices Market growth?

An absolute opportunity of USD 4.4 billion will be created between 2026 and 2036.

• Demand Drivers in the Market
  • Monitoring of high-risk pregnancies is expanding. Clinicians rely on devices that track fetal heart rate and wellbeing during pregnancy and labor, and that support rapid response when a trend turns abnormal.
  • Newborn intensive care capacity is growing. Neonatal monitors that track vital signs in premature and critically ill infants are a core purchase for hospitals building or upgrading neonatal units.
  • Portable and point-of-care devices are widening access. Compact ultrasound units and handheld dopplers let clinics and smaller facilities offer fetal assessment without fixed, high-cost installations.
  • Digital integration is raising device value. Connectivity with electronic records, central stations and remote review lets care teams act on data sooner.
• Key Segments Analyzed
  • By Product Type: Ultrasound Devices will hold 38.5% share in 2026, supported by their wide use in fetal assessment and imaging-led decisions.
  • By Portability: Portable devices will account for 55.8% share in 2026, owing to flexible use across wards, clinics and bedside settings.
  • By End-User: Hospitals will capture 57.3% share in 2026, given that they handle most deliveries, high-risk cases and neonatal admissions.
• Analyst Opinion at Fact.MR
  • Shambhu Nath Jha, Principal Consultant at Fact.MR, states, “Fetal and neonatal monitoring is now purchased as a continuous-surveillance capability rather than a standalone device. Providers will favor portable, interoperable systems that integrate ultrasound, fetal and neonatal data into unified workflows. Manufacturers pairing clinically validated platforms with analytics, training and service support will gain the most from hospitals and expanding care networks.”
• Strategic Implications
  • Device manufacturers should keep investing in portable, wireless designs, since portable systems already hold the majority share and buyers favor flexible deployment.
  • Suppliers of ultrasound and monitoring platforms should prioritize data connectivity and clear alarm design, so clinicians can read trends quickly and act with confidence.
  • Vendors targeting clinics and ambulatory surgical centers should pair compact devices with training and service support, because these buyers have smaller technical teams than hospitals.

Germany will lead at 8.4% CAGR. Brazil will follow at 7.7%. The United States will record 6.9%. The United Kingdom will post 6.2%, while Japan will close the range at 5.5%.

Ultrasound Devices will lead Product Type at 38.5%; Portable will lead Portability at 55.8%; Hospitals will lead End-User at 57.3%.

Which Product Type dominates?

Ultrasound Devices will hold 38.5% share in 2026.
 

Source: Fact.MR analysis. Updated Oct 12, 2026

Ultrasound leads because it supports both fetal assessment and wider obstetric workflows, and because one platform serves many clinical questions. Fetal dopplers remain a low-cost option for routine heart-rate checks in clinics and community settings. Fetal monitors serve labor and delivery, where continuous tracking guides decisions. Neonatal monitors support newborn and premature infant care in intensive units. Other devices complete the category. Shares for these remaining product types were not provided in the source data.

What supports Portable devices within Portability?

Portable devices will account for 55.8% share in 2026.
 

Source: Fact.MR analysis. Updated Oct 12, 2026

Portable systems lead because they move between wards, clinics and bedside settings and need less space and installation effort. Non-portable systems remain important for fixed delivery suites and neonatal units, where central stations and permanent mounting are standard.

What leads the End-User segment?

Hospitals will capture 57.3% share in 2026.
 

Source: Fact.MR analysis. Updated Oct 12, 2026

Hospitals lead because they manage most deliveries, high-risk pregnancies and neonatal admissions, and they hold the budgets for multi-bed monitoring systems. Clinics use compact ultrasound units and dopplers for routine prenatal care. Ambulatory surgical centers and other end-users add smaller but growing demand. Their individual shares were not provided in the source data.

Demand will rise through high-risk pregnancy monitoring, neonatal care expansion and portable technology. Growth is held back by equipment cost and the need for trained staff.

Drivers Impact Analysis

Source: Fact.MR analysis. Updated Oct 12, 2026

Opportunity Impact Analysis

Source: Fact.MR analysis. Updated Oct 12, 2026

Restraints Impact Analysis

Source: Fact.MR analysis. Updated Oct 12, 2026

Source: Fact.MR analysis. Updated Oct 12, 2026

What supports Germany adoption?

8.4% CAGR, the fastest among covered countries.

Germany combines a large, well-funded hospital system with steady replacement and upgrade cycles for monitoring equipment. Hospitals are well positioned to adopt connected, higher-specification devices, supported by strong clinical standards, structured procurement and sustained attention to maternal and neonatal safety.

How is Brazil scaling demand?

7.7% CAGR, driven by expanding access to maternal and neonatal care.

Investment in obstetric and neonatal capacity across public and private facilities is strengthening demand for ultrasound devices, fetal monitors and neonatal monitors. Broader care coverage and facility upgrades are expected to sustain procurement momentum through the forecast period.

What supports United States adoption?

6.9% CAGR, supported by an established and technology-ready care base.

The large installed base of hospital monitoring systems favors upgrades toward portable, networked and remote-capable devices. Providers are prioritizing interoperability and continuous surveillance, which supports steady replacement demand and the adoption of advanced monitoring platforms.

How does the United Kingdom perform?

6.2% CAGR, shaped by a mature public healthcare system.

Purchasing is steady and tied to maternity service priorities, with growth coming mainly from equipment replacement cycles and digital integration. Demand is expected to remain stable, favoring cost-effective, interoperable systems that improve clinical workflows and support safer maternity care.

What is shaping Japan’s demand?

5.5% CAGR, the lowest in the group, reflecting a mature market.

Japan has a highly developed obstetric and neonatal care system, so growth leans on technology upgrades rather than new capacity. Demand is likely to center on higher-precision, compact and connected devices that improve monitoring quality and support efficient care delivery.

The market is led by large, diversified medical technology groups that compete on product breadth, hospital relationships and integration with wider monitoring and imaging systems.

GE HealthCare offers Voluson ultrasound systems and Corometrics fetal monitors, while Philips Healthcare provides Avalon fetal monitors and IntelliVue patient monitoring. Medtronic contributes Nellcor pulse oximetry and Microstream capnography, and Drägerwerk AG adds neonatal incubators, warmers and monitoring solutions. Fujifilm SonoSite strengthens portable point-of-care ultrasound. Clinical evidence, reliability, connectivity and service coverage will decide competition through 2036

Key providers include GE HealthCare, Philips Healthcare, Medtronic, Drägerwerk AG, Natus Medical, Masimo, Fujifilm SonoSite, ICU Medical, and Edwards Lifesciences.

• GE HealthCare
• Philips Healthcare
• Medtronic
• Drägerwerk AG
• Natus Medical
• Masimo
• Fujifilm SonoSite
• ICU Medical
• Edwards Lifesciences

• [1] World Health Organization. (2025). WHO recommendations on maternal and newborn care for a positive postnatal experience: Updated guidance.
• [2] World Health Organization. (2025). Improving the quality of care for maternal, newborn and child health: Implementation guidance.
• [3] U.S. Food and Drug Administration. (2025). Obstetrical and gynecological devices: Regulatory considerations for fetal monitoring and ultrasound systems.
• [4] European Commission. (2025). Medical devices: Guidance on clinical evaluation and performance requirements under Regulation (EU) 2017/745.
• [5] National Institute for Health and Care Excellence. (2025). Fetal monitoring in labour: Clinical guidance and evidence review.
• [6] National Institute for Health and Care Excellence. (2025). Intrapartum care: Care of healthy women and their babies during childbirth.
• [7] Organisation for Economic Co-operation and Development. (2025). Health at a glance 2025: OECD indicators.
• [8] United Nations Children's Fund. (2025). Born too soon: Care for preterm babies and newborn health.
• [9] International Electrotechnical Commission. (2025). Medical electrical equipment: Particular requirements for the basic safety and essential performance of fetal and maternal monitors.

• The report explains how fetal and neonatal monitoring devices are used by product type, portability and end-user.
• Segment analysis identifies the subsegment that leads each segment and the clinical needs behind its 2026 share.
• Country analysis compares the five listed countries by growth rate through 2036.
• Competitive analysis reviews the leading medical technology provide

The Fetal and Neonatal Monitoring Devices Market covers medical devices used to monitor the health of the fetus during pregnancy and labor, and of newborns, including premature and critically ill infants. Typical products include ultrasound devices, fetal dopplers, fetal monitors and neonatal monitors, offered in portable and non-portable forms.

The assessment tracks devices sold to hospitals, clinics, ambulatory surgical centers and other care settings. These systems support early detection of distress, delivery decisions and newborn care, with growing demand for integrated, connected monitoring workflows.

What is included in the scope?

The scope includes ultrasound devices, fetal dopplers, fetal monitors and neonatal monitors used for the assessment and surveillance of mother and baby. It covers both portable and non-portable systems sold to hospitals, clinics, ambulatory surgical centers and other care settings.

Integrated monitoring systems are included when fetal or neonatal assessment forms the core function. Multi-purpose ultrasound platforms count only for their obstetric and neonatal applications.

What is excluded from the scope?

The scope excludes general adult patient monitors, standalone diagnostic imaging systems such as MRI and CT, and ultrasound platforms sold solely for non-obstetric uses such as cardiology or musculoskeletal imaging. Neonatal incubators, warmers and phototherapy equipment are also excluded unless sold as part of an integrated monitoring system.

Consumables, disposable sensors and accessories sold separately from the devices fall outside the revenue boundary. Software subscriptions, installation, maintenance and other services unrelated to device sales are excluded.

How Was the Analysis Built?

• Primary Research: Discussions with manufacturers, clinicians, hospital buyers and subject-matter experts on purchasing priorities, adoption and competitive positioning.
• Desk Research: Review of regulatory publications, company filings, trade data, clinical guidance and industry associations.
• Market Sizing and Forecasting: Estimates combine segment shares, country-level growth, adoption patterns and barriers to expansion.
• Data Validation and Update Cycle: Findings are cross-checked against public data and industry developments, with regular updates for launches, approvals and partnerships.